These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 15159412)
1. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment. de Melker AA; van der Horst G; Borst J J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819 [TBL] [Abstract][Full Text] [Related]
3. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors. Kowanetz K; Szymkiewicz I; Haglund K; Kowanetz M; Husnjak K; Taylor JD; Soubeyran P; Engstrom U; Ladbury JE; Dikic I J Biol Chem; 2003 Oct; 278(41):39735-46. PubMed ID: 12874286 [TBL] [Abstract][Full Text] [Related]
5. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011 [TBL] [Abstract][Full Text] [Related]
6. Cbl-mediated ubiquitinylation is required for lysosomal sorting of epidermal growth factor receptor but is dispensable for endocytosis. Duan L; Miura Y; Dimri M; Majumder B; Dodge IL; Reddi AL; Ghosh A; Fernandes N; Zhou P; Mullane-Robinson K; Rao N; Donoghue S; Rogers RA; Bowtell D; Naramura M; Gu H; Band V; Band H J Biol Chem; 2003 Aug; 278(31):28950-60. PubMed ID: 12754251 [TBL] [Abstract][Full Text] [Related]
7. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. Feshchenko EA; Smirnova EV; Swaminathan G; Teckchandani AM; Agrawal R; Band H; Zhang X; Annan RS; Carr SA; Tsygankov AY Oncogene; 2004 Jun; 23(27):4690-706. PubMed ID: 15107835 [TBL] [Abstract][Full Text] [Related]
8. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717 [TBL] [Abstract][Full Text] [Related]
9. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609 [TBL] [Abstract][Full Text] [Related]
10. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis. Huang F; Sorkin A Mol Biol Cell; 2005 Mar; 16(3):1268-81. PubMed ID: 15635092 [TBL] [Abstract][Full Text] [Related]
14. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. Kassenbrock CK; Anderson SM J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950 [TBL] [Abstract][Full Text] [Related]
15. Constitutive association of EGF receptor with the CrkII-23 mutant that inhibits transformation of NRK cells by EGF and TGF-beta. Ota S; Kizaka-Kondoh S; Hashimoto Y; Nishihara H; Nagashima K; Kurata T; Okayama H; Matsuda M Cell Signal; 1998 Apr; 10(4):283-90. PubMed ID: 9617486 [TBL] [Abstract][Full Text] [Related]
16. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor. Waterman H; Levkowitz G; Alroy I; Yarden Y J Biol Chem; 1999 Aug; 274(32):22151-4. PubMed ID: 10428778 [TBL] [Abstract][Full Text] [Related]
17. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively. Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581 [TBL] [Abstract][Full Text] [Related]
18. Negative regulation of Lck by Cbl ubiquitin ligase. Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function. Fong CW; Leong HF; Wong ES; Lim J; Yusoff P; Guy GR J Biol Chem; 2003 Aug; 278(35):33456-64. PubMed ID: 12815057 [TBL] [Abstract][Full Text] [Related]
20. c-Cbl-mediated ubiquitinylation is required for epidermal growth factor receptor exit from the early endosomes. Ravid T; Heidinger JM; Gee P; Khan EM; Goldkorn T J Biol Chem; 2004 Aug; 279(35):37153-62. PubMed ID: 15210722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]